Cadila Healthcare Limited announced today that the USFDA inspected its Topical manufacturing facility located at Changodar, Ahmedabad from 22nd March to 28th March, 2018. At the end of the inspection, no observation (483) is issued.
Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The group employs over 21000 people worldwide and is dedicated to creating healthier communities globally. Zydus aspires to be a research-based pharmaceutical company by 2020.